Literature DB >> 1859367

Specificity of dopachrome tautomerase and inhibition by carboxylated indoles. Considerations on the enzyme active site.

P Aroca1, F Solano, J C Garcia-Borrón, J A Lozano.   

Abstract

Dopachrome tautomerase (EC 5.3.2.3) catalyses the tautomerization of dopachrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA) within the melanin-formation pathway. We have analysed a series of substrate analogues and related compounds as possible substrates and inhibitors of tautomerization. The enzyme appears to be highly specific since D-dopachrome, alpha-methyldopachrome, dopaminochrome, adrenochrome methyl ether and deoxyadrenochrome are not substrates. Conversely, dopachrome tautomerase catalyses the tautomerization of dopachrome methyl ester, suggesting that a carboxy group, either free or as a methyl ester, is essential for enzyme recognition. No inhibition of dopachrome tautomerization was observed in the presence of either semiquinonic compounds, such as tropolone and L-mimosine, or pyrrole-2-carboxylic acid and unsubstituted indole. However, a number of indole derivatives, including DHICA, the product of dopachrome tautomerization, and the analogues 5-hydroxyindole-2-carboxylic and indole-2-carboxylic acid were able to inhibit the enzyme. Furthermore, indoles with a side chain at position 3 of the ring and containing a carboxylic group at the gamma-position of this chain, such as L-tryptophan or indole-3-propionic acid, are stronger inhibitors of the enzyme. Indole-3-carboxylic acid, indole-3-acetic acid and indole-3-butyric acid are very weak inhibitors, showing that the carboxylic group needs to be located at an optimal distance from the indole ring to mimic the carboxylic group at position 2 on the authentic substrate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1859367      PMCID: PMC1151246          DOI: 10.1042/bj2770393

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  A new spectrophotometric assay for dopachrome tautomerase.

Authors:  P Aroca; F Solano; J C García-Borrón; J A Lozano
Journal:  J Biochem Biophys Methods       Date:  1990-06

2.  Biochemistry of melanin formation.

Authors:  A B LERNER; T B FITZPATRICK
Journal:  Physiol Rev       Date:  1950-01       Impact factor: 37.312

3.  Dopachrome conversion factor functions as an isomerase.

Authors:  J M Pawelek
Journal:  Biochem Biophys Res Commun       Date:  1990-02-14       Impact factor: 3.575

4.  A kinetic study of the melanization pathway between L-tyrosine and dopachrome.

Authors:  J Cabanes; F García-Cánovas; J A Lozano; F García-Carmona
Journal:  Biochim Biophys Acta       Date:  1987-02-20

5.  Dopachrome conversion: a possible control point in melanin biosynthesis.

Authors:  A M Körner; J Pawelek
Journal:  J Invest Dermatol       Date:  1980-08       Impact factor: 8.551

6.  Regulation of mammalian melanogenesis. I: Partial purification and characterization of a dopachrome converting factor: dopachrome tautomerase.

Authors:  P Aroca; J C Garcia-Borron; F Solano; J A Lozano
Journal:  Biochim Biophys Acta       Date:  1990-09-14

7.  Dopachrome oxidoreductase: a new enzyme in the pigment pathway.

Authors:  J I Barber; D Townsend; D P Olds; R A King
Journal:  J Invest Dermatol       Date:  1984-08       Impact factor: 8.551

8.  Function of dopachrome oxidoreductase and metal ions in dopachrome conversion in the eumelanin pathway.

Authors:  L J Leonard; D Townsend; R A King
Journal:  Biochemistry       Date:  1988-08-09       Impact factor: 3.162

9.  Preparation of eumelanin-related metabolites 5,6-dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, and their O-methyl derivatives.

Authors:  K Wakamatsu; S Ito
Journal:  Anal Biochem       Date:  1988-05-01       Impact factor: 3.365

10.  Structural modifications in biosynthetic melanins induced by metal ions.

Authors:  A Palumbo; M d'Ischia; G Misuraca; G Prota; T M Schultz
Journal:  Biochim Biophys Acta       Date:  1988-02-17
View more
  14 in total

1.  Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Authors:  Athar Alam; Saikat Haldar; Hirekodathakallu V Thulasiram; Rahul Kumar; Manish Goyal; Mohd Shameel Iqbal; Chinmay Pal; Sumanta Dey; Samik Bindu; Souvik Sarkar; Uttam Pal; Nakul C Maiti; Uday Bandyopadhyay
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  The action of glycosylases on dopachrome (2-carboxy-2,3-dihydroindole-5,6-quinone) tautomerase.

Authors:  P Aroca; J H Martinez-Liarte; F Solano; J C García-Borrón; J A Lozano
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention.

Authors:  Zachary R Healy; Hua Liu; W David Holtzclaw; Paul Talalay
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-20       Impact factor: 4.254

4.  A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease.

Authors:  Aaron P Kithcart; Gina M Cox; Thais Sielecki; Abigail Short; James Pruitt; Tracey Papenfuss; Todd Shawler; Ingrid Gienapp; Abhay R Satoskar; Caroline C Whitacre
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

Review 5.  Melanization in living organisms: a perspective of species evolution.

Authors:  Christopher J Vavricka; Bruce M Christensen; Jianyong Li
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

6.  The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction.

Authors:  E Rosengren; R Bucala; P Aman; L Jacobsson; G Odh; C N Metz; H Rorsman
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

7.  Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis.

Authors:  Shilpa Choudhary; Poornima Hegde; James R Pruitt; Thais M Sielecki; Dharamainder Choudhary; Kristen Scarpato; David J Degraff; Carol C Pilbeam; John A Taylor
Journal:  Carcinogenesis       Date:  2013-07-03       Impact factor: 4.944

8.  Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification.

Authors:  F Solano; V J Hearing; J C García-Borrón
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

9.  A new dopachrome-rearranging enzyme from the ejected ink of the cuttlefish Sepia officinalis.

Authors:  A Palumbo; M d'Ischia; G Misuraca; L De Martino; G Prota
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

10.  Molecular mechanism for catalysis by a new zinc-enzyme, dopachrome tautomerase.

Authors:  F Solano; C Jiménez-Cervantes; J H Martínez-Liarte; J C García-Borrón; J R Jara; J A Lozano
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.